- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07810673
Physical Performance and Quality of Life in Children With Brain Tumors
September 3, 2026 updated by: Sarah Mohammed El-Abasiri
ASSESSMENT OF PHYSICAL PERFORMANCE AND QUALITY OF LIFE IN CHILDREN WITH BRAIN TUMORS.
This study is designed to assess physical performance and quality of life in children with posterior fossa brain tumors compared to healthy children.
The trial evaluates parameters such as physical endurance, balance, muscle strength, gait characteristics, and quality of life measures to understand the functional impact of the condition.
Study Overview
Status
Recruiting
Study Type
Observational
Enrollment (Estimated)
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Sarah Mohammed El-Abasiri
- Phone Number: +20 10 91906219
- Email: d.ahmed.saber1987@gmail.com
Study Locations
-
-
-
Cairo, Egypt
- Recruiting
- Maadi Military Hospital
-
Contact:
- Sara M Elabasiry Mohamed, MSc
- Phone Number: +20 10 91906219
- Email: d.ahmed.saber1987@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Pediatric patients diagnosed with posterior fossa brain tumors recruited from treatment centers, alongside an age-matched group of healthy children serving as controls.
Description
Inclusion Criteria:
- - Children aged 7 to 10 years.
- Confirmed diagnosis of posterior fossa brain tumors.
- Medically stable and able to perform physical evaluations.
Inclusion Criteria for Healthy Controls:
- Age-matched healthy children aged 7 to 10 years.
- No history of neurological, musculoskeletal, or oncological disorders.
Exclusion Criteria:
- Associated severe cognitive or visual impairments preventing test comprehension.
- Other concurrent major medical or orthopedic conditions affecting physical performance.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Posterior Fossa Brain Tumor Group
Children aged 7 to 10 years diagnosed with posterior fossa brain tumors.
|
|
Healthy Control Group
Age-matched healthy children acting as a control group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
6-Minute Walk Test (6MWT)
Time Frame: At baseline during the initial assessment
|
Measures walking distance in meters to evaluate physical endurance and functional capacity.
|
At baseline during the initial assessment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Eman Ibrahim Elhadidy, Cairo University Faculty of Physical Therapy
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2025
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 25, 2026
Study Registration Dates
First Submitted
September 3, 2026
First Submitted That Met QC Criteria
September 3, 2026
First Posted (Actual)
September 9, 2026
Study Record Updates
Last Update Posted (Actual)
September 9, 2026
Last Update Submitted That Met QC Criteria
September 3, 2026
Last Verified
September 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- P.T.REC/012/006217
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.